Demographics & Encounter
Patient ID255347 (PHI redacted)
Age / Gender59 / Male
Date of Service2026-04-06
Provider[PROVIDER_NAME]
FacilityPOTOMAC UROLOGY CENTER - Alexandria
PayerCareFirst BCBS
Reason1. surgical consultation/Cath change
Diagnoses
R97.20
Elevated prostate specific antigen (PSA)
N17.9
Acute renal failure (ARF)
N40.1
Benign prostatic hyperplasia with lower urinary tract symptoms
N32.81
OAB (overactive bladder)
R33.9
Urinary retention
Clinical Summary (HPI)
General Urology: 59 yM presents today to review renal ultrasound and catheter change. On presentation his Cr was 4.2 (11/2025), His Discharge Cr was 2.4. His Cr was 1.8 (12/05/2025). -------------------------------------------------- Prior Hx: 11/04/2025 Fu for BPH, OAB, and ED Tamsulosin HCl 0.4 MG Capsule 1 cap(s) orally once a day with minimal improvement. Weak stream, nocturia x2. + urge inconti. Interested in maintaining sexual activity. He got PSA from PCP. Not sexually active. Endorses ED. Not interested in discussing today. Denies dysuria, GH, UTIs, history of kidney stones, or FHx of prostate cancer. 12/23/25 Hosp FU for sepsis, UTI, AUR, AKI in the setting of BOO; presents today with a foley catheter in place. Admitted 11/8-11/14 with N/V and generalized malaise. He was tx with IV abx and foley placement, which also improved Cr from 3.5 to 2.4. Advised to continue flomax. 01/06/2026 FU urine retention, elevated PSA, BPH, and OAB 02/10/2026 He has a cath in place.
Raw Note (de-identified preview)
4/23/26, 6:48 AM Print Preview
[PATIENT_NAME] DOB: [DOB] (59 yo M) Acc No. [ACCOUNT_ID] DOS: 04/06/2026
[PATIENT_NAME]
59 Y old Male, DOB: [DOB]
Account: [ACCOUNT_ID]
[ADDRESS]
Home: [PHONE]
Guarantor: [GUARANTOR_NAME] Insurance: CareFirst BCBS
PCP: [PROVIDER_NAME] Referring: [PROVIDER_NAME]
Appointment Facility: POTOMAC UROLOGY CENTER - Alexandria
04/06/2026 Progress Notes: [PROVIDER_NAME], MD
Reason for Appointment
1. surgical consultation/Cath change
History of Present Illness
General Urology:
59 yM presents today to review renal ultrasound and catheter change.
On presentation his Cr was 4.2 (11/2025), His Discharge Cr was 2.4. His Cr was 1.8 (12/05/2025).
--------------------------------------------------
Prior Hx:
11/04/2025
Fu for BPH, OAB, and ED
Tamsulosin HCl 0.4 MG Capsule 1 cap(s) orally once a day with minimal improvement.
Weak stream, nocturia x2.
+ urge inconti.
Interested in maintaining sexual activity.
He got PSA from PCP.
Not sexually active. Endorses ED. Not interested in discussing today.
Denies dysuria, GH, UTIs, history of kidney stones, or FHx of prostate cancer.
12/23/25
Hosp FU for sepsis, UTI, AUR, AKI in the setting of BOO; presents today with a foley catheter in place.
Admitted 11/8-11/14 with N/V and generalized malaise. He was tx with IV abx and foley placement, which also improved Cr
from 3.5 to 2.4. Advised to continue flomax.
01/06/2026
FU urine retention, elevated PSA, BPH, and OAB
02/10/2026
He has a cath in place.
Current Medications
Taking
Carvedilol 3.125 MG Tablet Oral
Tamsulosin HCl 0.4 MG Capsule 1 cap(s) orally once a day
Medication List reviewed and reconciled with the patient
Past Medical History
No Reported Medical History.
Medical History Verified.
Progress Note: [PROVIDER_NAME], MD 04/06/2026
Note generated by eClinicalWorks EMR/PM Software (www.eClinicalWorks.com)
Generated for Printing/Faxing/eTransmitting on: 04/23/2026 09:48 AM EDT
1/4
4/23/26, 6:48 AM Print Preview
[PATIENT_NAME] DOB: [DOB] (59 yo M) Acc No. [ACCOUNT_ID] DOS: 04/06/2026
Surgical History
Denies
Family History
Father: deceased
Mother: deceased
Social History
Smoking: no
Recreational drug use: no.
Exercise: yes.
Caffeine: yes, frequency:.
Sexually active: no.
Screening
Allergies
N.K.D.A.
Hospitalization/Major Diagnostic Procedure
Bladder outlet obstruction 11/2025
swollen prostate/inova 3/2026
Vital Signs
Assessments
1.Elevated prostate specific antigen (PSA) - R97.20 (Primary)
2.Acute renal failure (ARF) - N17.9
3.Benign prostatic hyperplasia with lower urinary tract symptoms - N40.1
4.OAB (overactive bladder) - N32.81
5.Urinary retention - R33.9
Treatment
1.Elevated prostate specific antigen (PSA)
Notes: DRE: PV 100 g. Areas of nodularity noted (11/04/2025).
PSA: 19.07 (11/2025), 6.7 (06/2025); 2.3 ng/ml (10/10/2023)
4k score: 28 (11/2025)
pMRI (12/2025): No PIRADS 3. Pros vol 52 cc.
FQ Resist GNR (01/2026): Negative
Cysto, transperineal prostate needle biopsy (03/26): No urethral abnormalities. Prostate median lobe
only. Bladder